SynthesisThe Cochrane database of systematic reviews2021

Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer.

Siao-Nge Hoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.